ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed net income
Net income is the profit left for shareholders after every expense, interest and tax.
ResMed's net income for the twelve months ending Jun 30, 2026 was $1.52B, up 8.8% year over year. For fiscal 2026 it was $1.52B, up 8.8% from the year before. Over ten years it grew 15.8% a year on average. The highest annual figure on record is $1.52B in fiscal 2026.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.52B | +8.8% |
| FY2025 | Jun 30, 2025 | $1.40B | +37.2% |
| FY2024 | Jun 30, 2024 | $1.02B | +13.7% |
| FY2023 | Jun 30, 2023 | $897.56M | +15.2% |
| FY2022 | Jun 30, 2022 | $779.44M | +64.3% |
| FY2021 | Jun 30, 2021 | $474.51M | -23.7% |
| FY2020 | Jun 30, 2020 | $621.67M | +53.7% |
| FY2019 | Jun 30, 2019 | $404.59M | +28.2% |
| FY2018 | Jun 30, 2018 | $315.59M | -7.8% |
| FY2017 | Jun 30, 2017 | $342.28M | -2.9% |
| FY2016 | Jun 30, 2016 | $352.41M | -0.1% |
| FY2015 | Jun 30, 2015 | $352.89M | +2.2% |
| FY2014 | Jun 30, 2014 | $345.27M | +12.4% |
| FY2013 | Jun 30, 2013 | $307.13M | +20.5% |
| FY2012 | Jun 30, 2012 | $254.85M | +12.3% |
| FY2011 | Jun 30, 2011 | $226.99M | +19.4% |
| FY2010 | Jun 30, 2010 | $190.09M | +29.8% |
| FY2009 | Jun 30, 2009 | $146.45M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $383.43M | +1.0% |
| Q3 FY2026 | Mar 31, 2026 | $398.73M | +9.2% |
| Q2 FY2026 | Dec 31, 2025 | $392.59M | +13.9% |
| Q1 FY2026 | Sep 30, 2025 | $348.54M | +11.9% |
| Q4 FY2025 | Jun 30, 2025 | $379.71M | +29.9% |
| Q3 FY2025 | Mar 31, 2025 | $365.04M | +21.5% |
| Q2 FY2025 | Dec 31, 2024 | $344.62M | +65.0% |
| Q1 FY2025 | Sep 30, 2024 | $311.36M | +41.9% |
| Q4 FY2024 | Jun 30, 2024 | $292.24M | +27.2% |
| Q3 FY2024 | Mar 31, 2024 | $300.49M | +29.2% |
| Q2 FY2024 | Dec 31, 2023 | $208.80M | -7.2% |
| Q1 FY2024 | Sep 30, 2023 | $219.42M | +4.2% |
| Q4 FY2023 | Jun 30, 2023 | $229.66M | +17.7% |
| Q3 FY2023 | Mar 31, 2023 | $232.50M | +29.9% |
| Q2 FY2023 | Dec 31, 2022 | $224.91M | +11.5% |
| Q1 FY2023 | Sep 30, 2022 | $210.48M | +3.4% |
| Q4 FY2022 | Jun 30, 2022 | $195.06M | -0.0% |
| Q3 FY2022 | Mar 31, 2022 | $179.01M | – |
| Q2 FY2022 | Dec 31, 2021 | $201.75M | +12.4% |
| Q1 FY2022 | Sep 30, 2021 | $203.61M | +14.2% |
| Q4 FY2021 | Jun 30, 2021 | $195.10M | +9.7% |
| Q3 FY2021 | Mar 31, 2021 | -$78.48M | -148.1% |
| Q2 FY2021 | Dec 31, 2020 | $179.51M | +11.8% |
| Q1 FY2021 | Sep 30, 2020 | $178.37M | +48.5% |
| Q4 FY2020 | Jun 30, 2020 | $177.84M | +158.5% |
| Q3 FY2020 | Mar 31, 2020 | $163.14M | +54.8% |
| Q2 FY2020 | Dec 31, 2019 | $160.55M | +28.8% |
| Q1 FY2020 | Sep 30, 2019 | $120.15M | +13.6% |
| Q4 FY2019 | Jun 30, 2019 | $68.80M | -37.3% |
| Q3 FY2019 | Mar 31, 2019 | $105.42M | -4.3% |
| Q2 FY2019 | Dec 31, 2018 | $124.64M | +1208.3% |
| Q1 FY2019 | Sep 30, 2018 | $105.74M | +22.8% |
| Q4 FY2018 | Jun 30, 2018 | $109.81M | +8.1% |
| Q3 FY2018 | Mar 31, 2018 | $110.13M | +25.4% |
| Q2 FY2018 | Dec 31, 2017 | $9.53M | -87.6% |
| Q1 FY2018 | Sep 30, 2017 | $86.13M | +13.2% |
| Q4 FY2017 | Jun 30, 2017 | $101.61M | – |
| Q3 FY2017 | Mar 31, 2017 | $87.82M | – |
| Q2 FY2017 | Dec 31, 2016 | $76.74M | – |
| Q1 FY2017 | Sep 30, 2016 | $76.11M | – |